FDA Inspection 1218310 — David B. DeLurgio, M.D.
The FDA completed an inspection of David B. DeLurgio, M.D. on September 11, 2023 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 11, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Atlanta, GA (United States)
Additional Details
Clinical Investigator (CI)